RXST logo

RXST RxSight, Inc.

NASDAQ Global Market · Medical - Devices · Healthcare

$4.47
-0.14 (-3.04%)

As a medical technology enterprise, RxSight, Inc. (which operated as Calhoun Vision, Inc. until its rebranding in February 2017) specializes in the innovation, manufacturing, and distribution of light-adjustable intraocular lenses (LALs). These advanced lenses are specifically designed for use in cataract surgery, serving patients in both domestic and international markets. The cornerstone of the …

Market Cap: $187.42Mwww.rxsight.com

Price

No data yet.

Social Signal Score

50
5d
50
1 mentions
—
30d
50
4 mentions
—
60d
50
6 mentions
—
90d
50
7 mentions
—
news: 7

Analyst Ratings

12 analysts
Holdconsensus
Strong Buy 0Buy 3Hold 7Sell 2Strong Sell 0
Avg price target$6.06+35.6%
Low $5.5Median $5.88High $7
Current Consensus

Revenue

$24.59M+751.32%
$2.71M$16.94M$31.17M$45.41M
Mar 2020Sep 2026

Analyst Estimates

FY2025
$-1.05
$-1.13–$-0.94
3 analysts
FY2026
$-0.80
$-1.87–$0.27
5 analysts
FY2027
$-1.21
$-1.55–$-0.87
5 analysts

Consensus estimates, not results. Via Financial Modeling Prep.

Company Profile

CEO
Aziz Mottiwala
Sector
Healthcare
Industry
Medical - Devices
Employees
461
Beta
1.19
Country
US
Piotroski score
2 / 9 (Weak)
Altman Z-score
-0.90
www.rxsight.com